• Relugolix 120mg

Relugolix 120mg

SKU:52073

Relugolix is used to lower testosterone in adults with advanced prostate cancer.

Relugolix is also used in combination products with hormone add-back treatment for heavy menstrual bleeding from uterine fibroids and for moderate to severe pain from endometriosis.

Usual adult prostate cancer dose: 360mg on the first day, then 120mg once daily; fixed-combination gynaecology products contain relugolix 40mg once daily with hormone add-back therapy.


Indications vary by country and change over time; this website contains information for general patient information and should be checked against local prescribing information before clinical use.

Verification Approach: Each indication and usual dose-range sentence was drafted from at least two recognised medicines information sources, usually FDA/DailyMed or an FDA label plus EMA/eMC, MedlinePlus, Mayo Clinic, Cancer Research UK, NCI/ Cancer.gov, or another reputable medicines-information source. Doses are general adult/patient-information ranges and must not be used to prescribe or change treatment.


  • FDA/DailyMed prescribing information and FDA Oncology/Hematology approval notifications.
  • EMA and UK eMC Summary of Product
    Characteristics and patient leaflets where available.
  • NCI Cancer Drug Information/Cancer.gov and Cancer Research UK medicine information where available.
  • MedlinePlus, NHS/NICE, and other national medicines information for non-oncology or immune/respiratory medicines.
  • Peer-reviewed FDA approval summaries or manufacturer regulatory notices for very new, withdrawn, or region-specific
    indications.